Document is current
Any future updates will be listed below
-
Authors
Du, Jiayuan
Tan, Tianmeng
Yu, Yaojie
Wang, He
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82160443)
the Guangxi Natural Science Foundation (2020GXNSFAA159023)
the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education (02402215010D)
the Thousand-Hundred Ten Talent Project of Guangxi Province (2015226)
the 139 Medical High-level Talents Training Plan of Guangxi Province (G201903032)
the Guangxi Medical and Health Appropriate Technology Development and Application Project (S2024088)
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 13 May 2025
First Online: 26 May 2025
Declarations
:
: This study was approved by the Institutional Ethics Committee of Guangxi Medical University Affiliated Cancer Hospital (Approval Number: LW2024087). And This study collected cervical tissue specimens from patients with normal and precancerous cervical lesions confirmed by pathological diagnosis, which had been registered in the national medical research filing system and published in the Chinese Clinical Trial Registry. And the study had signed informed consent forms for all participants. The data of this study were not published. All methods were carried out in accordance with the Declaration of Helsinki. Clinical trial number: not applicable in our manuscript.
: Not applicable.
: The authors declare no competing interests.
